Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KAPA

Kairos Pharma Ltd

Jun 11 • 04:00PM ET

0.4582

+0.0282 6.56 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: APRE BCDA BIVI CALC CVM GOVX KPRX NEUP AIM JAGX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	40.92%	Shs Outstand	21.41M	Perf Week	-1.67%
Market Cap	9.81M	Forward P/E	-	EPS next Y	-0.67	Insider Trans	0.00%	Shs Float	12.65M	Perf Month	-5.53%
Enterprise Value	6.14M	PEG	-	EPS next Q	-0.09	Inst Own	2.81%	Short Float	1.24%	Perf Quarter	-23.63%
Income	-5.84M	P/S	-	EPS this Y	-23.33%	Inst Trans	-8.51%	Short Ratio	1.21	Perf Half Y	-46.67%
Sales	0.00M	P/B	1.85	EPS next Y	-81.08%	ROA	-85.36%	Short Interest	0.16M	Perf YTD	-35.46%
Book/sh	0.25	P/C	2.67	EPS next 5Y	-	ROE	-93.84%	52W High	2.11 -78.28%	Perf Year	-6.62%
Cash/sh	0.17	P/FCF	-	EPS past 3/5Y	-53.52% -29.30%	ROIC	-109.90%	52W Low	0.43 6.56%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.17% 9.42%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-17.50%	Oper. Margin	-	ATR (14)	0.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.31	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	40.70	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.31	EPS Q/Q	1.01%	SMA20	-5.66%	Beta	1.43	Target Price	8.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-15.81%	Rel Volume	0.90	Prev Close	0.43
Employees	4	LT Debt/Eq	0.00	Earnings	Jun 03	SMA200	-44.05%	Avg Volume	129.55K	Price	0.46
IPO	Sep 16, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	116,123	Change	6.56%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)